User: Stage 1: History (Timestamp: 23 September)
A 26-year-old woman, a bank employee from the NCR region (BMI 19.5 kg/m²), presents with colicky abdominal pain, multiple episodes of vomiting, and reduced oral intake. She has no fever. Examination shows a dehydrated patient with blood pressure 80/60 mmHg. She is treated as acute gastroenteritis with intravenous fluids and a proton pump inhibitor, and improves. Labs on Day 1: Hb 8.7 g/dL, TLC 3,890/µL (low), neutrophils ~50%, CRP 59 mg/L. Day 2: Hb 9.6 g/dL, neutrophils 40%, ANC calculated ~3,000/µL (borderline low). She is discharged after recovery.
Hello, Chief Resident here.
Key Findings:
A 26-year-old female (BMI 19.5 kg/m²) presenting with acute colicky abdominal pain, vomiting, marked hypotension (80/60 mmHg), leukopenia (TLC 3,890/µL), anemia, and significantly elevated CRP (59 mg/L), showing fluid-responsive improvement.
Differential Diagnoses:
1. Acute Gastroenteritis with severe hypovolemia (40%): Explains acute GI presentation and fluid response, though cytopenias require vigilance.
2. Adrenal Insufficiency / Impending Addisonian Crisis (25%): Hypotension, low BMI, abdominal pain, and vomiting fit an adrenal axis defect triggered by acute stress.
3. Autoimmune Etiology (e.g., SLE) (20%): Young female with bicytopenia (anemia, leukopenia), high CRP, and serositis/abdominal pain.
4. Endemic Infection (Enteric Fever / Abdominal TB) (15%): Leukopenia, elevated CRP, abdominal pain, and low BMI in an endemic setting.
Recommended Next Tests:
1. Serum Electrolytes (Na+, K+): Check for hyponatremia/hyperkalemia suggesting adrenal insufficiency.
2. Morning Serum Cortisol & ACTH level: Rule out hypoadrenalism.
3. USG Abdomen and Pelvis: Evaluate for intra-abdominal inflammation, lymphadenopathy, or appendicitis.
4. ANA by IFA & Peripheral Blood Smear: Evaluate for autoimmune disease and cytopenia etiology.
5. Blood/Stool Cultures & Typhidot: Rule out enteric pathogens.
Hello Attending Consultant here
Critique: Solid initial resuscitation and DDx breadth, but overweights simple AGE given bicytopenia + CRP elevation without source control. Misses early cortisol/ACTH and smear review; typhidot low-yield vs cultures. PPI unnecessary without ulcer risk.
Top 3 DDx:
1. Addisonian crisis (primary adrenal failure)
2. SLE with mesenteric vasculitis/serositis
3. Enteric fever (Salmonella) with marrow suppression
Specific points:
1. Immediate electrolytes + random cortisol/ACTH pre-steroids.
2. Peripheral smear + retic count for hemolysis/marrow.
3. ANA/ENA + C3/C4 urgently.
4. Blood cultures ×2 before abx; hold empiric unless septic.
5. AM cortisol stim test if random low.
6. CT abdomen if pain recurs (nodes/vasculitis).
7. Discharge only after ANC >1.5 and endocrine clearance.
Hello, Expert Clinician here.
Best current diagnosis: Acute gastrointestinal illness causing severe dehydration and fluid-responsive hypovolemic shock. However, “gastroenteritis” does not explain the anemia and leukopenia, which require independent evaluation; a definitive unifying diagnosis is not yet established.
Top differentials
- Adrenal crisis: Vomiting, abdominal pain, and hypotension fit, but rapid fluid response and absent reported hyponatremia, hyperkalemia, hypoglycemia, or chronic features weaken it.
- Systemic autoimmune disease (especially SLE): Young woman with anemia and leukopenia; less convincing without rash, arthritis, renal findings, or serositis. CRP 59 mg/L favors infection over uncomplicated SLE activity.
- Enteric/systemic infection: Cytopenia and elevated CRP fit, but absence of fever and rapid recovery argue against typhoid or sepsis.
- Occult blood loss, nutritional deficiency, or marrow disorder: Important explanations for Hb 8.7–9.6 g/dL but unlikely to account for the acute GI syndrome.
Key pivot: The reported ANC is incorrect: TLC 3,890/µL with 40–50% neutrophils gives an ANC around 1,550–1,950/µL, not 3,000.
Next move: Repeat CBC with manual differential, smear, reticulocyte count, iron/B12/folate studies, electrolytes, renal function, glucose, and pregnancy testing. If hypotension recurs or electrolytes suggest adrenal failure, obtain cortisol/ACTH and treat promptly.
Teaching pearl: Fluid-responsive shock supports hypovolemia but does not exclude adrenal insufficiency.
User: Stage 2: Readmission with Septic Shock (Timestamp: 13 October)
Three weeks later she returns with fever (103°F), dehydration, multiple episodes of vomiting, upper abdominal pain, cough, and shortness of breath. On arrival she is severely dehydrated with systolic BP 70 mmHg - a picture of septic shock. She is admitted to the ICU and started on broad-spectrum antibiotics with NIV and oxygen support. Additional history: recurrent abdominal pain for the past several months, prior consultation with a gastroenterologist at another hospital, and a history of recurrent oral ulcers. No clear history of unpasteurized milk or zoonotic exposure.
Hello, Chief Resident here.
Updated Key Findings:
Readmission of a 26-year-old female with septic shock (BP 70 mmHg), high fever (103°F), respiratory failure requiring NIV, upper abdominal pain, and a key history of recurrent oral ulcers and chronic abdominal pain.
Differential Diagnoses:
1. Systemic Lupus Erythematosus (SLE) with Serositis/Vasculitis (40%): Bicytopenia, oral ulcers, chronic GI pain, and pulmonary involvement (lupus pneumonitis/diffuse alveolar hemorrhage or secondary sepsis).
2. Behcet's Disease (25%): Recurrent oral ulcers, intestinal Behcet's (chronic pain), and pulmonary vasculitis/aneurysms causing respiratory distress and shock.
3. Disseminated Tuberculosis with ARDS (20%): Endemic setting, low BMI, chronic abdominal symptoms, acute high fever, and secondary respiratory failure.
4. Severe Intra-abdominal Sepsis e.g., Crohn's perforation (15%): Oral ulcers, chronic abdominal pain presenting with septic shock and ARDS.
Prioritized Next Tests:
1. CT Chest & Abdomen with Contrast: Evaluate for intra-abdominal sepsis/perforation and lung parenchymal/vascular lesions.
2. Autoimmune Panel (ANA by IFA, Anti-dsDNA, C3/C4): Workup for SLE/vasculitis.
3. Blood & Sputum Cultures + GeneXpert MTB: Identify causative bacterial pathogens or tuberculosis.
4. Bedside POCUS / Echocardiogram: Assess volume status, cardiac function, and serosal effusions.
5. Peripheral Smear & Repeat CBC: Monitor cytopenias and hemolysis.
Hello Attending Consultant here
Critique: Strong incorporation of oral ulcers and chronic pain elevating SLE/Behçet; CT and autoimmune panel appropriately prioritized. Overweights Crohn’s (less likely without diarrhea/fistulae). Misses adrenal axis re-evaluation amid recurrent shock and ignores HLH screen given cytopenias + fever. NIV/abx correct, but delay in pathergy/HLA-B51 and smear review.
Top 3 DDx:
1. SLE flare (mesenteric vasculitis + pneumonitis/secondary sepsis)
2. Behçet’s (intestinal + pulmonary arterial involvement)
3. Disseminated TB (abdominal + ARDS)
Specific points:
1. Urgent ANA/dsDNA/C3/C4 + antiphospholipid Abs.
2. Pathergy test + HLA-B51; ophthalmology for uveitis.
3. Random cortisol/ACTH + electrolytes pre-steroids.
4. CT pulmonary angiogram (rule out aneurysms/emboli).
5. Ferritin/triglycerides/sIL-2R for HLH.
6. GeneXpert + IGRA; hold steroids until infection excluded.
7. Repeat smear/retic + Coombs for ongoing cytopenias.
Hello, Expert Clinician here.
Best current unifying diagnosis: Severe systemic infection causing septic shock, with brucellosis an important leading consideration given prolonged/recurrent abdominal symptoms, fever, cytopenias, and pulmonary/systemic involvement. Absence of recognized livestock or unpasteurized-dairy exposure does not exclude it.
Top differentials
- Brucellosis ± secondary HLH: Fits recurrent systemic illness, cytopenias, abdominal symptoms, and shock; pulmonary disease and fulminant shock are uncommon but recognized.
- Enteric fever or disseminated tuberculosis: Both can produce fever, abdominal symptoms, cytopenias, and respiratory deterioration; the abrupt shock favors bacterial sepsis over TB.
- SLE with secondary infection/mesenteric vasculitis: Oral ulcers and cytopenias support SLE, but high fever, CRP elevation, dehydration, and shock strongly prioritize infection.
- Behçet disease: Recurrent oral ulcers and abdominal/pulmonary disease fit, but diagnosis requires genital ulcers, ocular/skin disease, or vascular findings; septic physiology is not explained adequately.
Key pivot: Recurrent shock after an earlier unexplained leukopenic illness suggests one evolving systemic process—not isolated gastroenteritis. Oral ulcers are a clue, not a diagnosis.
Next move: Continue guideline-based shock resuscitation, obtain multiple blood cultures with prolonged incubation and alert microbiology for Brucella, send Brucella serology/PCR, and perform contrast CT chest/abdomen. Check ferritin, triglycerides, fibrinogen, and organomegaly for HLH.
Teaching pearl: Epidemiologic exposure is often not elicited in brucellosis; laboratory notification also reduces aerosol risk.
User: Stage 3: Progressive Neutropenia (Timestamp: 14-16 October)
CBC in ICU shows a progressive fall in TLC from 3.8 to 2.5 x 10^3/µL, neutrophils falling to 6% then 2%, with an ANC of 0.04 x 10^3/µL (severe neutropenia). Lymphocytes ~60%, monocytes ~30% with metamyelocytes. Platelets ~1.9 x 10^5/µL (normal). Hb 8.1 g/dL. Procalcitonin elevated at 9.43 ng/mL. LFT/KFT normal. Blood and urine cultures negative. Viral markers (HBsAg, anti-HCV, HIV) negative. Dengue serology positive but platelet count normal; Brucella serology positive with no clear exposure history; Leptospira and scrub typhus negative. Stool occult blood positive. Chest X-ray shows bilateral haziness; CT chest shows bilateral lower lobe pneumonia. CT abdomen shows diffuse mural thickening of bowel with mild free fluid in pelvis.
Hello, Chief Resident here.
Key Findings:
Severe agranulocytosis (ANC 0.04×10³/µL), positive Brucella and Dengue serology, elevated procalcitonin (9.43 ng/mL), CT showing diffuse bowel wall thickening (enteritis) and bilateral pneumonia, and stool occult blood positivity.
Differential Diagnoses:
1. Disseminated Brucellosis with Bone Marrow Suppression (45%): Positive serology, profound neutropenia, bowel wall thickening, pneumonia, and septic shock.
2. Neutropenic Enterocolitis (Typhlitis) & Secondary Sepsis (25%): Mucosal breakdown from agranulocytosis leading to bacterial translocation, enteritis, secondary pneumonia, and shock.
3. SLE with Lupus Enteritis & Autoimmune Neutropenia (20%): Unifies chronic abdominal pain, oral ulcers, diffuse enteritis, and cytopenias.
4. Secondary HLH (Infection/Autoimmune Triggered) (10%): Severe marrow suppression and multiorgan involvement driven by Brucella, Dengue, or autoimmune activity.
Prioritized Next Steps:
1. Administer G-CSF (Filgrastim): Urgently treat profound agranulocytosis in the setting of septic shock.
2. Bone Marrow Aspiration & Biopsy: Evaluate for marrow aplasia, hemophagocytosis, granul
Hello Attending Consultant here
Critique: Correct urgency on G-CSF and marrow exam; dual positive serologies (Brucella/Dengue) over-interpreted without titers/PCR confirmation—Dengue unlikely with preserved platelets. Misses immediate Brucella-directed therapy and HLH criteria scoring amid agranulocytosis + multiorgan failure. Cultures negative does not exclude intracellular pathogens.
Top 3 DDx:
1. Disseminated brucellosis (marrow suppression + enterocolitis/pneumonia)
2. SLE/autoimmune neutropenia with neutropenic enterocolitis + secondary sepsis
3. Infection-triggered HLH (Brucella/Dengue)
Specific points:
1. Start doxycycline + aminoglycoside/rifampin empirically for Brucella.
2. Urgent BM aspirate/biopsy + culture (hemophagocytosis, granulomas).
3. G-CSF immediately; reverse isolation.
4. Ferritin, TG, fibrinogen, sIL-2R to score HLH-2004.
5. Repeat Brucella SAT/PCR + Dengue NS1/PCR (ignore IgM alone).
6. ANA/dsDNA/C3/C4 + direct Coombs.
7. Hold steroids pending infection exclusion; serial PCT/ANC.
Hello, Expert Clinician here.
Best unifying diagnosis: Cyclic neutropenia, now at its approximately 21-day neutrophil nadir, complicated by febrile agranulocytosis, bilateral pneumonia, and neutropenic enterocolitis, causing septic shock. Recurrent oral ulcers and months of episodic abdominal pain are classic manifestations.
Top differentials
- Drug-induced agranulocytosis: Consider recent antibiotics or other medications, but neutropenia was present before ICU therapy and the three-week recurrence favors cyclic disease.
- Autoimmune neutropenia/SLE: Oral ulcers and leukopenia fit, but isolated profound neutropenia with preserved platelets and normal renal function is less typical; obtain ANA, dsDNA, complements.
- Marrow failure, leukemia, or HLH: Require marrow assessment, although normal platelets/LFTs and absence of broader pancytopenia argue against them.
- Brucellosis/dengue: Positive serology may reflect cross-reactivity or prior infection. Neither adequately explains the periodic isolated agranulocytosis; confirm with titers/PCR or cultures before disease-specific therapy.
Key pivot: The recurrence almost exactly three weeks after the initial leukopenic episode, together with recurrent oral ulcers, strongly indicates a cyclic ANC nadir.
Immediate move: Treat as high-risk febrile neutropenia with IV antipseudomonal antibiotics, G-CSF, bowel rest, and surgical monitoring—avoid colonoscopy. After stabilization, obtain CBCs 2–3 times weekly for six weeks, marrow examination, and ELANE testing.
Teaching pearl: Cyclic neutropenia often first presents through oral ulcers and recurrent “gastroenteritis” at 21-day intervals.
User: Stage 4: Workup for Neutropenia (Timestamp: 18-20 October)
Peripheral smear shows anemia with markedly decreased neutrophils. Autoimmune workup (ANA, RF, anti-dsDNA, ANCA screen) is negative. Serum B12 is normal; patient is vegetarian. Bone marrow biopsy shows dimorphic anemia with myeloid maturation arrest (left shift), increased precursors/macrophages, blasts ~4%; other cell lines relatively preserved. Chronic or acquired neutropenia with maturation arrest is suspected. Endoscopy shows gastric erosions suspicious for fungal infection (chronic gastritis). The neutrophil count recovers transiently (ANC 3.55, then 8.36, then 8.6 x 10^3/µL).
Hello, Chief Resident here.
Updated Key Findings:
A 26-year-old female with periodic severe neutropenia, mouth ulcers, enteritis, and rapid ANC recovery (0.04 to 8.6 × 10³/µL). Negative autoimmune screen (ANA/dsDNA/ANCA). Bone marrow shows myeloid maturation arrest with 4% blasts. Gastric erosions suspect for opportunistic fungal infection.
Differential Diagnoses:
1. Cyclic Neutropenia (ELANE gene mutation) (60%): Tri-weekly periodicity (~21 days), maturation arrest during nadir, recurrent mucosal ulcers, periodic enteritis, and rapid ANC normalization.
2. Severe Chronic/Autoimmune Neutropenia (Seronegative) (20%): Maturation arrest and fluctuating ANC, though less strictly periodic.
3. Drug-Induced Agranulocytosis (Rebound Phase) (10%): Explains transient maturation arrest and rapid recovery, but fails to explain pre-existing monthly symptoms.
4. Low-Grade Myelodysplastic Syndrome (MDS) (10%): Suggested by 4% blasts and dimorphic anemia, though rapid complete neutrophil recovery makes this less likely.
Prioritized Next Steps:
1. Genetic Testing (ELANE gene sequencing): Definitive test for cyclic neutropenia.
2. Serial CBCs with Manual Differential: Draw 2–3 times weekly for 4–6 weeks to track periodic ANC oscillation.
3. Targeted Antifungal Therapy (e.g., Fluconazole/Echinocandin): Treat gastric fungal erosions.
4. Anti-Neutrophil Antibodies: Rule out peripheral destruction.
5. Maintenance G-CSF Protocol: Prevent future life-threatening agranulocytic sepsis.
Hello Attending Consultant here
Critique: Excellent prioritization of ELANE and serial CBCs given periodicity + maturation arrest + rebound. Overweights MDS (4% blasts nonspecific; rapid full recovery excludes). Fungal erosions unconfirmed—biopsy/culture first. Misses copper/folate (vegetarian) and anti-neutrophil Ab timing.
Top 3 DDx:
1. Cyclic neutropenia (ELANE-related)
2. Severe congenital neutropenia (non-cyclic ELANE/HAX1)
3. Idiopathic chronic neutropenia with maturation arrest
Specific points:
1. ELANE sequencing + extended congenital neutropenia panel.
2. CBC 3×/week ×6 weeks to document 21-day cycles.
3. Serum copper, folate, zinc (nutritional arrest).
4. Gastric biopsy + fungal stains/culture before antifungals.
5. Anti-neutrophil Abs during nadir.
6. Prophylactic G-CSF (1–3 µg/kg q1–3d) post-recovery.
7. Avoid empiric steroids; monitor for MDS evolution.
Hello, Expert Clinician here.
Best unifying diagnosis: Cyclic neutropenia, likely ELANE-associated, complicated at the nadir by febrile agranulocytosis, neutropenic enterocolitis, pneumonia, and septic shock. Recurrent oral ulcers, an approximately three-week interval between episodes, marrow myeloid maturation arrest, preserved megakaryocytic/erythroid lines, and rapid ANC rebound strongly support this.
Top differentials
- Drug-induced agranulocytosis: Maturation arrest and recovery fit, but neutropenia and recurrent symptoms preceded recent antibiotics; review all medications.
- Chronic idiopathic/autoimmune neutropenia: Possible despite negative serologies, but profound periodic oscillation is less typical.
- Severe congenital neutropenia: Also causes maturation arrest and ELANE variants, but usually produces persistent neutropenia beginning in childhood rather than discrete cycles.
- MDS/leukemia: Dimorphic anemia warrants cytogenetic review, but 4% blasts, preserved platelets, and brisk ANC normalization argue against it.
Key pivot: Recovery from ANC 0.04 to >8 ×10³/µL is not marrow failure; combined with the 21-day pattern, it indicates oscillating granulopoiesis.
Next move: Obtain CBC with differential three times weekly for six weeks and perform ELANE sequencing/congenital-neutropenia panel. Continue individualized G-CSF and urgent febrile-neutropenia protocols. Biopsy gastric lesions with fungal stains/culture before labeling invasive fungal disease.
Teaching pearl: Marrow in cyclic neutropenia varies by cycle; maturation arrest is most evident near the ANC nadir.
User: Stage 5: Management and Cyclical Pattern (Timestamp: 23 October)
Management includes broad-spectrum antibiotics (meropenem) plus antifungal cover, a single dose of G-CSF (filgrastim) 3 µg/kg subcutaneous, and empirical cyclosporin for possible immune-mediated neutropenia. The patient improves, is weaned off vasopressors, and by 23 October her TLC is ~10,000/µL with neutrophils 48.4% (ANC ~6,000/µL). There have been four admissions over 2-3 months. Serial CBC charts show a cyclical (periodic) pattern, with TLC and neutrophil counts rising and falling repeatedly over time. A next-generation sequencing (NGS) panel for inherited causes of neutropenia is sent.
Hello, Chief Resident here.
Key Findings:
Demonstrated periodic oscillation of ANC (ranging from severe agranulocytosis 0.04 to >8.0 × 10³/µL) across four admissions in 3 months, presenting with recurrent oral ulcers, enterocolitis, pneumonia, and septic shock at the nadir, followed by rapid recovery.
Differential Diagnoses:
1. Cyclic Neutropenia (ELANE mutation) (80%): Pathognomonic ~21-day periodicity, marrow maturation arrest, oral ulcers, and life-threatening infections at the neutrophil nadir.
2. Severe Congenital Neutropenia / Atypical Hereditary Variant (15%): Other genetic variants (HAX1, G6PC3, WAS) causing fluctuating myelopoiesis.
3. Autoimmune Oscillating Neutropenia (5%): Rare acquired T-cell or antibody-driven periodic marrow suppression.
Prioritized Next Steps:
1. Await NGS Results: Confirm ELANE or related pathogenic mutations.
2. Initiate Maintenance G-CSF: Start low-dose regular Filgrastim (1–3 µg/kg/day or alternate days) to prevent severe nadirs and septic shock.
3. Continue Serial CBC Tracking: Monitor 2–3 times weekly to map exact cycle kinetics.
4. Emergency Febrile Neutropenia Protocol: Educate patient on immediate broad-spectrum antibiotics upon fever.
5. Taper Cyclosporine: Wean empiric immunosuppression once genetic etiologies are confirmed to avoid unnecessary infection risks.
Hello Attending Consultant here
Critique: Strong recognition of periodicity and G-CSF maintenance; NGS correctly prioritized. Cyclosporin empiric use unjustified (negative autoimmune serologies, infection risk); overweights atypical hereditary variants without childhood history. Misses cycle-length documentation and infection prophylaxis details.
Top 3 DDx:
1. Cyclic neutropenia (ELANE-related)
2. Severe congenital neutropenia (ELANE/HAX1 non-cyclic)
3. Idiopathic/cyclic autoimmune neutropenia
Specific points:
1. Discontinue cyclosporin immediately (no immune evidence).
2. Confirm ~21-day cycles via thrice-weekly CBC ×6–8 weeks.
3. Start scheduled G-CSF 1–3 µg/kg q1–3d targeting ANC >1.0–1.5.
4. Await NGS (ELANE primary; expand if negative).
5. Pneumococcal/Hib/influenza vaccines + dental hygiene.
6. Home fever protocol: immediate ED + antipseudomonal abx.
7. Family screening if ELANE+; avoid marrow stimulants long-term without genetics.
Hello, Expert Clinician here.
Best unifying diagnosis: Cyclic neutropenia, most likely ELANE-associated, complicated during profound ANC nadirs by oral ulceration, neutropenic enterocolitis, pneumonia, and septic shock. Repeated oscillation over several months, preserved platelets, marrow myeloid maturation arrest, and recovery to normal/high ANC strongly support oscillating granulopoiesis.
Top differentials
- Chronic idiopathic/autoimmune neutropenia: Possible if genetic testing is negative, but negative autoimmune studies and reproducible periodicity make it less likely.
- Severe congenital neutropenia: Can show ELANE-related maturation arrest, but typically causes persistent childhood-onset neutropenia rather than discrete adult cycles.
- Drug-induced agranulocytosis: Medication review remains essential, although it does not explain recurrent pre-treatment episodes and cyclical counts.
- MDS/leukemia: Unlikely given preserved other lineages, only 4% blasts, and brisk ANC normalization.
Key pivot: Objective serial CBCs now demonstrate recurrent oscillations; however, the latest rise is partly G-CSF-associated and should not alone define cycle length.
Most important move: Establish scheduled low-dose G-CSF titrated to prevent ANC nadirs, continue CBCs 2–3 times weekly for 6–8 weeks, and review the NGS panel. Stop cyclosporine unless immune-mediated disease is demonstrated.
Teaching pearl: In cyclic neutropenia, preventing the nadir—not normalizing every CBC—reduces infections and mucosal disease.
User: Stage 6: Final Results
NGS confirms a pathogenic ELANE gene mutation. Diagnosis: Cyclic neutropenia (autosomal dominant neutrophil elastase defect), classically presenting with recurrent oral ulcers, cyclical fevers, infections (pneumonia/enterocolitis) and the characteristic ~21-day cycling of the absolute neutrophil count. Recurrent oral ulcers + recurrent abdominal pain + cyclical leucopenic pattern on serial CBCs is the classic diagnostic triad. Bone marrow at the trough shows myeloid maturation arrest. Management: G-CSF (filgrastim) is the mainstay, given prophylactically to raise the ANC and shorten the nadir; cyclosporin/steroids have a limited adjunctive role in immune-mediated cases. Genetic confirmation has implications for surveillance (risk of MDS/AML in the SCN end of the spectrum) and genetic counselling.
Hello, Chief Resident here.
Key Findings:
Confirmed pathogenic ELANE gene mutation on NGS, establishing the definitive diagnostic triad of cyclic neutropenia: recurrent oral ulcers, chronic abdominal pain (neutropenic enterocolitis), and periodic (~21-day) severe agranulocytosis.
Final Diagnosis:
1. Cyclic Neutropenia (ELANE mutation) (100%): Confirmed by genetic testing, unifying the myeloid maturation arrest at the nadir, oscillating ANC, mucosal ulceration, and recurrent septic shock.
Prioritized Management & Next Steps:
1. Maintenance G-CSF (Filgrastim): Initiate prophylactic low-dose G-CSF (1–3 µg/kg/day or alternate days) to elevate the ANC nadir and prevent severe sepsis.
2. Discontinue Cyclosporine: Taper off empiric immunosuppression immediately to avoid unnecessary opportunistic infection risk.
3. Genetic Counseling: Provide autosomal dominant genetic counseling and offer target testing for first-degree family members.
4. MDS/AML Surveillance: Establish long-term routine CBC monitoring and maintain a low threshold for bone marrow evaluation to screen for leukemic transformation.
5. Patient Education: Reiterate emergency febrile neutropenia protocols for immediate ED evaluation and broad-spectrum antibiotics during nadir periods.
Hello Attending Consultant here
Critique: Excellent closure on ELANE confirmation and triad recognition; G-CSF mainstay and cyclosporin cessation correctly prioritized. Under-emphasizes precise nadir-targeted dosing, MDS/AML risk stratification, and family cascade testing logistics. No mention of dental/oral hygiene protocols or vaccine optimization.
Top 3 DDx:
1. ELANE-cyclic neutropenia (confirmed)
2. ELANE-severe congenital neutropenia (non-cyclic spectrum)
3. Secondary cyclic neutropenia (rare acquired mimics)
Specific points:
1. Titrate G-CSF 1–3 µg/kg q1–3d to keep nadir ANC >0.5–1.0 ×10³/µL.
2. Thrice-weekly CBC ×2 cycles then monthly lifelong.
3. Annual marrow + cytogenetics for MDS/AML surveillance.
4. Immediate cascade ELANE testing + counseling for first-degree relatives.
5. Optimize oral hygiene, pneumococcal/Hib/influenza vaccines.
6. Home fever action card: ED + antipseudomonal abx within 1 h.
7. Avoid unnecessary immunosuppressants; document cycle length precisely.
Hello, Expert Clinician here.
Unifying diagnosis: Genetically confirmed ELANE-associated cyclic neutropenia, complicated at ANC nadirs by oral ulceration, neutropenic enterocolitis, pneumonia, and septic shock. The ~21-day ANC oscillation, marrow myeloid maturation arrest at the trough, preserved platelets, and rapid count recovery are characteristic.
Remaining differentials:
- ELANE-associated severe congenital neutropenia: Same genetic spectrum, but persistent childhood-onset neutropenia rather than regular cycling argues against it.
- Autoimmune, drug-induced, or idiopathic neutropenia: Effectively displaced by the reproducible cyclic pattern and pathogenic ELANE variant.
- MDS/leukemia: Not currently supported by 4% blasts, preserved lineages, and count normalization.
Key pivot: Serial CBCs transformed apparently unrelated episodes of “gastroenteritis,” oral ulcers, and sepsis into a periodic granulopoietic disorder; NGS confirmed the mechanism.
Most important move: Begin individualized prophylactic filgrastim, titrated to shorten the nadir and prevent severe infection, with hematology follow-up and CBC monitoring. Stop cyclosporine unless a separate immune indication emerges. Any fever requires immediate evaluation and empiric antipseudomonal antibiotics. Provide autosomal-dominant genetic counseling and family testing.
Teaching pearl: Leukemic evolution is chiefly a concern in severe congenital neutropenia; risk in classic cyclic neutropenia is substantially lower, so surveillance should be individualized.